| 1 |
34466729 | High-throughput drug screening models of mature adipose tissues which replicate the physiology of patients' Body Mass Index (BMI). | 2022 Jan |
1 |
| 2 |
34637354 | Is Shift Work Sleep Disorder a Risk Factor for Metabolic Syndrome and Its Components? A Systematic Review of Cross-Sectional Studies. | 2022 Feb |
1 |
| 3 |
34953312 | Melatonin alleviates insulin resistance through the PI3K/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome. | 2022 Mar |
1 |
| 4 |
35007648 | Diabetes mellitus and melatonin: Where are we? | 2022 Jan 7 |
1 |
| 5 |
35133678 | Unanticipated daytime melatonin secretion on a simulated night shift schedule generates a distinctive 24-h melatonin rhythm with antiphasic daytime and nighttime peaks. | 2022 Apr |
1 |
| 6 |
35140394 | Interactions between nocturnal melatonin secretion, metabolism, and sleeping behavior in adolescents with obesity. | 2022 May |
1 |
| 7 |
35173531 | The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease. | 2022 |
1 |
| 8 |
35178208 | Effect of melatonin on stress-induced hyperglycemia and insulin resistance in critically-ill patients: A randomized double-blind, placebo-controlled clinical trial. | 2022 Winter |
2 |
| 9 |
35455066 | Anti-Inflammatory Effects of Melatonin in Rats with Induced Type 2 Diabetes Mellitus. | 2022 Apr 12 |
1 |
| 10 |
35619221 | Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial. | 2022 May 26 |
5 |
| 11 |
33220095 | Acute metabolic effects of melatonin-A randomized crossover study in healthy young men. | 2021 Mar |
2 |
| 12 |
33706965 | Melatonin and healthy aging. | 2021 |
1 |
| 13 |
33932966 | Presence of Peripheral Neuropathy Does Not Affect Urine 6-Sulfatoxymelatonin Levels in Type 2 Diabetics. | 2021 Mar |
1 |
| 14 |
34092248 | Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. | 2021 Jun 6 |
1 |
| 15 |
34229264 | Effects of melatonin supplementation on diabetes: A systematic review and meta-analysis of randomized clinical trials. | 2021 Jul |
1 |
| 16 |
34265066 | The Effect of Melatonin on Incretin Hormones: Results From Experimental and Randomized Clinical Studies. | 2021 Nov 19 |
1 |
| 17 |
34370338 | Effects of daily administration of melatonin before bedtime on fasting insulin, glucose and insulin sensitivity in healthy adults and patients with metabolic diseases. A systematic review and meta-analysis. | 2021 Nov |
6 |
| 18 |
34496412 | Effects of Melatonin Supplementation on Insulin Levels and Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2021 Sep |
8 |
| 19 |
34582575 | The effect of melatonin on glucose tolerance, insulin sensitivity and lipid profiles after a late evening meal in healthy young males. | 2021 Dec |
2 |
| 20 |
31355852 | Elucidating the Regulatory Role of Melatonin in Brown, White, and Beige Adipocytes. | 2020 Mar 1 |
1 |
| 21 |
31597622 | The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2020 May |
3 |
| 22 |
32417629 | Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial. | 2020 Aug |
1 |
| 23 |
33520862 | Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus. | 2020 Dec |
1 |
| 24 |
33571963 | Nanomolar melatonin influences insulin synthesis and secretion in rat insulinoma INS-1E cells. | 2020 Oct |
9 |
| 25 |
29275919 | Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. | 2019 Feb |
1 |
| 26 |
29637854 | Melatonin and Oxidative Stress in the Diabetic State: Clinical Implications and Potential Therapeutic Applications. | 2019 |
1 |
| 27 |
30831541 | Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. | 2019 May 1 |
1 |
| 28 |
31264419 | Monitoring Insulin-Aggregated Structures in the Presence of Epigallocatechin-3-gallate and Melatonin by Molecular Dynamics Simulations. | 2019 Jul 22 |
4 |
| 29 |
31421432 | Reduced melatonin synthesis in pregnant night workers: Metabolic implications for offspring. | 2019 Nov |
1 |
| 30 |
31693492 | A new prospective on the role of melatonin in diabetes and its complications. | 2019 Nov 6 |
1 |
| 31 |
28558523 | Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study. | 2018 Feb |
1 |
| 32 |
29415446 | Melatonin: A Molecule for Reducing Breast Cancer Risk. | 2018 Feb 6 |
1 |
| 33 |
29706998 | Melatonin Treatment Improves Insulin Resistance and Pigmentation in Obese Patients with Acanthosis Nigricans. | 2018 |
5 |
| 34 |
29727655 | Human insulin fibrillogenesis in the presence of epigallocatechin gallate and melatonin: Structural insights from a biophysical approach. | 2018 Aug |
1 |
| 35 |
30103453 | Melatonin Uptake by Cells: An Answer to Its Relationship with Glucose? | 2018 Aug 10 |
1 |
| 36 |
30396207 | The Effects of Melatonin Supplementation on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2018 Nov |
2 |
| 37 |
27165273 | Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies. | 2017 |
1 |
| 38 |
27763686 | Melatonin and the pathologies of weakened or dysregulated circadian oscillators. | 2017 Jan |
1 |
| 39 |
27981356 | Chronomedicine and type 2 diabetes: shining some light on melatonin. | 2017 May |
2 |
| 40 |
28303303 | Melatonin signalling and type 2 diabetes risk: too little, too much or just right? | 2017 May |
1 |
| 41 |
28604593 | Melatonin Modulates Neuronal Cell Death Induced by Endoplasmic Reticulum Stress under Insulin Resistance Condition. | 2017 Jun 10 |
2 |
| 42 |
28764741 | The role of melatonin in the onset and progression of type 3 diabetes. | 2017 Aug 1 |
2 |
| 43 |
29328029 | [METABOLIC SECRETION IN REPRODUCTIVE AGE WOMEN WITH OBESITY]. | 2017 Dec |
1 |
| 44 |
26549462 | Influence of nutrient restriction and melatonin supplementation of pregnant ewes on maternal and fetal pancreatic digestive enzymes and insulin-containing clusters. | 2016 Mar |
2 |
| 45 |
26853813 | Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis. | 2016 Feb |
1 |
| 46 |
27185156 | Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes. | 2016 Jun 14 |
1 |
| 47 |
27264986 | Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review. | 2016 Sep |
1 |
| 48 |
25892993 | Shift work and endocrine disorders. | 2015 |
2 |
| 49 |
25904189 | Experimental and clinical aspects of melatonin and clock genes in diabetes. | 2015 Aug |
4 |
| 50 |
25922310 | MTNR1B gene polymorphisms and susceptibility to Type 2 Diabetes: A pilot study in South Indians. | 2015 Jul 25 |
1 |